Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07602647
Perioperative Safety and Long-Term Outcomes of Mesh Repair in Nonagenarians Undergoing Elective Inguinal Hernia RepairFudan UniversityNot Yet Recruiting
NCT07602647Not Yet Recruiting
—
Perioperative Safety and Long-Term Outcomes of Mesh Repair in Nonagenarians Unde...Fudan University
NCT07603388
Effects of Pelvic Floor Rehab Protocol on Urinary IncontinenceRiphah International UniversityActive Not RecruitingNot Applicable
NCT07603388Active Not Recruiting
Not Applicable
Effects of Pelvic Floor Rehab Protocol on Urinary IncontinenceRiphah International Univ...
NCT07605234
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Photobiomodulation as an Adjunct to Standard Supportive Care for Chemotherapy Induced Oral Mucositis in Pediatric Patients With Hematolymphoid MalignanciesTata Memorial HospitalNot Yet RecruitingNot Applicable
NCT07605234Not Yet Recruiting
Not Applicable
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Ph...Tata Memorial Hospital
NCT07601269
Replacement of the Native Mitral Valve Using the ReValve SystemReValve Solutions Inc.RecruitingEarly Phase 1
NCT07601269Recruiting
Early Phase 1
Replacement of the Native Mitral Valve Using the ReValve SystemReValve Solutions Inc.
NCT07600775
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)Merck Sharp & Dohme LLCNot Yet RecruitingPhase 1
NCT07600775Not Yet Recruiting
Phase 1
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuber...Merck Sharp & Dohme LLC
NCT07603466
Combination Osilodrostat and Cabergoline in Cushing's DiseaseUniversity of BasrahEnrolling By InvitationPhase 4
NCT07603466Enrolling By Invitation
Phase 4
Combination Osilodrostat and Cabergoline in Cushing's DiseaseUniversity of Basrah
NCT07602036
Type 2 Diabetes and Pregnancy a Single-arm Interventional StudyMedtronicNot Yet RecruitingNot Applicable
NCT07602036Not Yet Recruiting
Not Applicable
Type 2 Diabetes and Pregnancy a Single-arm Interventional StudyMedtronic
NCT07604571
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast CancerNovartis PharmaceuticalsNot Yet RecruitingPhase 1
NCT07604571Not Yet Recruiting
Phase 1
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/...Novartis Pharmaceuticals
NCT07601997
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study)Myomed Technology (Shaoxing) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07601997Not Yet Recruiting
Not Applicable
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reper...Myomed Technology (Shaoxi...
NCT07603037
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion Ratio in Patients With Acute Respiratory FailureFirst Affiliated Hospital of Wannan Medical CollegeNot Yet RecruitingNot Applicable
NCT07603037Not Yet Recruiting
Not Applicable
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion...First Affiliated Hospital...
NCT07604623
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Cardiac SurgeryUniversity of AlbertaNot Yet RecruitingNot Applicable
NCT07604623Not Yet Recruiting
Not Applicable
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Ca...University of Alberta
NCT07603128
Multicenter Validation of a Risk Prediction Model for MDRGNB InfectionRuijin HospitalNot Yet Recruiting
NCT07603128Not Yet Recruiting
—
Multicenter Validation of a Risk Prediction Model for MDRGNB InfectionRuijin Hospital
NCT07602426
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of resO™ Bone and Joint Support Postbiotic on Physical Function, Pain Interference, and Mobility in Adults With Joint DiscomfortAble Biolabs, LLCActive Not RecruitingNot Applicable
NCT07602426Active Not Recruiting
Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of...Able Biolabs, LLC
NCT07604233
Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AMLM.D. Anderson Cancer CenterNot Yet RecruitingPhase 1
NCT07604233Not Yet Recruiting
Phase 1
Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AMLM.D. Anderson Cancer Cent...
NCT07603011
Effect of Catheter Duration on Prostate Laser Enucleation Surgery Outcomes in Patients With Urinary RetentionAnkara UniversityRecruiting
NCT07603011Recruiting
—
Effect of Catheter Duration on Prostate Laser Enucleation Surgery Outcomes in Pa...Ankara University
NCT07605117
Isoinertial Training in Patients With COPDUniversidad Manuela BeltránNot Yet RecruitingNot Applicable
NCT07605117Not Yet Recruiting
Not Applicable
Isoinertial Training in Patients With COPDUniversidad Manuela Beltr...
NCT07605338
To Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis.Colgate PalmoliveActive Not RecruitingPhase 3
NCT07605338Active Not Recruiting
Phase 3
To Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established...Colgate Palmolive
NCT07602608
Platelet-Rich Plasma With or Without Tadalafil for Erectile DysfunctionBenha UniversityCompletedPhase 4
NCT07602608Completed
Phase 4
Platelet-Rich Plasma With or Without Tadalafil for Erectile DysfunctionBenha University
NCT07604909
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant ChemotherapyFudan UniversityRecruitingPhase 2
NCT07604909Recruiting
Phase 2
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Thera...Fudan University
NCT07604636
Adjunctive Ozone Therapy for Residual Periodontal PocketsAtaturk UniversityCompletedNot Applicable
NCT07604636Completed
Not Applicable
Adjunctive Ozone Therapy for Residual Periodontal PocketsAtaturk University
Result Breakdown
Not yet recruiting11 (55%)
Active, not recruiting3 (15%)
Recruiting3 (15%)
Completed2 (10%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Not Specified3 (15%)
Phase 13 (15%)
Phase 42 (10%)
Early Phase 11 (5%)
Phase 31 (5%)
Phase 21 (5%)